I
Innovent Biologics
Sustainability Report and Carbon Intensity Rankings
Is Innovent Biologics doing their part?
Their DitchCarbon score is 43
Innovent Biologics has a DitchCarbon Score of 43 out of 100, indicating moderate performance in sustainability practices. This score reflects the company’s current carbon intensity level, suggesting there is significant room for improvement in reducing emissions. A higher score would denote a lower carbon intensity and better alignment with environmental sustainability goals.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Innovent Biologics is part of the research and development sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Innovent Biologics, based in China, operates in a region with a specific carbon intensity rating. The sustainability of the company’s operations is influenced by China’s overall carbon intensity, affecting its environmental impact.
Unlock 30+ emissions data points on Innovent Biologics
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Innovent Biologics
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
8.36%
...this company is doing 8.36% worse in emissions than the industry average.
Innovent Biologics, founded in August 2011 and headquartered in Suzhou City, operates within the research and development sector of the biopharmaceutical industry. The company is dedicated to creating affordable, high-quality biopharmaceutical products for both the Chinese market and international consumers, adhering to global cGMP standards. Innovent has forged significant partnerships, including a strategic alliance with Eli Lilly & Company, and has earned recognition for its innovative contributions to science and technology in China.
emission intelligence's platform recommendations for Innovent Biologics
Innovent Biologics should consider implementing green procurement policies to source low-carbon energy and services, which could potentially reduce their emissions by 30%.
Bad news, Innovent Biologics hasn't committed to SBTi goals yet.
Innovent Biologics has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is either in the process of setting or has not publicly disclosed its goals for reducing greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.